CSRXP RELEASES MEMBER PACKET FOR 117TH CONGRESS
Feb 8, 2021
Resource Provides Information on Out-of-Control Drug Prices — Outlines… Read More
© 2024 CSRXP- All Rights Reserved
Press Release
CSRxP: BIDEN ADMINISTRATION TAKES IMPORTANT STEP TO PROTECT SENIORS & TAXPAYERS WITH DELAY OF REBATE RULE
Jan 29, 2021
HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on… Read More
CSRXP POLL: AMERICANS EXPECT NEW ADMINISTRATION & CONGRESS TO ACT ON OUT-OF-CONTROL DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE
Jan 26, 2021
Clear Majority of Voters Identify Rx Drug Affordability as Top Issue and… Read More
CSRXP WELCOMES GOVERNOR CUOMO INVESTIGATION OF DRUG COMPANIES’ PANDEMIC PRICE-GOUGING
Jan 22, 2021
Investigation Will Shed Light On Big Pharma’s Price Hikes During Public… Read More
CSRXP: SENATE FINANCE REPORT HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRACTICES THAT RAISE INSULIN PRICES
Jan 14, 2021
Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike… Read More
CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE
Jan 12, 2021
Misguided Policy Published in Violation of Legally Required Process for Public… Read More
HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021
Jan 4, 2021
Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As… Read More
CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Dec 7, 2020
Campaign Looks Forward to Working with Becerra to Lower Drug Prices… Read More
CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM
Dec 3, 2020
Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide… Read More
CSRxP: MISGUIDED REBATE RULE A BIG PHARMA BAILOUT PAID FOR BY AMERICAN SENIORS & TAXPAYERS
Nov 20, 2020
Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries… Read More
CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS
Nov 9, 2020
Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to… Read More
CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP
Oct 30, 2020
Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir… Read More